ER and PR expressions were also associated with improved survival even after adjusting for age, tumor site, stage, and histological grade at diagnosis [Hazard Ratio: 0.33, 95% Confidence Interval (CI) 0.21–0.51; p < 0.0001)]. This evidence concerns the gene ESR1 and neoplasm.